Through the 90-day period concluding February 19, 2026, Outlook Therapeutics's top three insider stakeholders include Director Ghiath M. Sukhtian (13.55Mn shares), Director Faisal Ghiath Sukhtian (2.79Mn shares), TenPercentOwner Ventures Llc Syntone (1.71Mn shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Faisal Ghiath Sukhtian | 2,794,239 | 11 Oct, 2022 | |
| Pte Ltd. Biolexis | 1,149,126 | 22 Apr, 2022 | |
| Arun Kumar Pillai | 1,149,126 | 01 Feb, 2022 | |
| Ghiath M. Sukhtian | 13,552,359 | 28 May, 2025 | |
| Ventures Llc Syntone | 1,705,438 | 17 Apr, 2024 | |
| Jeff Evanson | Chief Commercial Officer | 40,423 | 11 Mar, 2024 |
| Terry Dagnon | Chief Operations Officer | 32,653 | 21 Apr, 2023 |
| Kurt J Hilzinger | 23,656 | 05 Oct, 2022 | |
| C Russell Iii Trenary | Ceo And President | 2,746 | 23 Jun, 2022 |
| Lawrence A Kenyon | Chief Financial Officer | 5,946 | 30 Sep, 2024 |
| Yezan Munther Haddadin | 5,049 | 29 Mar, 2024 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 27 May, 2025 | Ghiath M. Sukhtian | Common Stock | A | 4,285,714 | $1.40 | 13,552,359 | I | A |
| 17 Jan, 2025 | Ghiath M. Sukhtian | Common Stock | A | 3,458,571 | $2.51 | 9,266,645 | I | M |
| 26 Sep, 2024 | Lawrence A Kenyon | Common Stock | A | 5,000 | $5.69 | 5,946 | D | P |
| 26 Sep, 2024 | Lawrence A Kenyon | - | - | 5,946 | D | |||
| 15 Apr, 2024 | Ventures Llc Syntone | Common Stock | A | 714,286 | - | 1,705,438 | D | P |
| 15 Apr, 2024 | Ventures Llc Syntone | - | - | 1,705,438 | D | |||
| 28 Mar, 2024 | Yezan Munther Haddadin | Common Stock | A | 1,882 | $11.82 | 5,049 | D | P |
| 28 Mar, 2024 | Yezan Munther Haddadin | - | - | 5,049 | D | |||
| 18 Mar, 2024 | Ghiath M. Sukhtian | - | - | 5,808,074 | I | |||
| 18 Mar, 2024 | Ghiath M. Sukhtian | Common Stock | A | 2,305,714 | - | 5,808,074 | I | A |
| 07 Mar, 2024 | Jeff Evanson | - | - | 40,423 | D | |||
| 07 Mar, 2024 | Jeff Evanson | Common Stock | A | 62,484 | $0.42 | 40,423 | D | P |
| 20 Apr, 2023 | Terry Dagnon | - | - | 32,653 | D | |||
| 20 Apr, 2023 | Terry Dagnon | Common Stock | D | 520,000 | $1.14 | 32,653 | D | S |
| 20 Jan, 2023 | Jeff Evanson | Common Stock | D | 267,000 | $1.11 | 37,299 | D | S |
| 20 Jan, 2023 | Jeff Evanson | - | - | 37,299 | D | |||
| 19 Jan, 2023 | Jeff Evanson | - | - | 50,649 | D | |||
| 19 Jan, 2023 | Jeff Evanson | Common Stock | D | 103,255 | $1.22 | 50,649 | D | S |
| 18 Jan, 2023 | Jeff Evanson | Common Stock | D | 33,738 | $1.25 | 55,812 | D | S |
| 18 Jan, 2023 | Jeff Evanson | - | - | 55,812 | D |